Related Experiment Video
Updated: Apr 26, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Glioblastoma: background, standard treatment paradigms, and supportive care considerations
Susan V Ellor1, Teri Ann Pagano-Young, Nicholas G Avgeropoulos
1Currently in the intern year of her Neurology residency at the Duke University Medical Center.
Abstract:
Glioblastoma is a brain tumor condition marked by rapid neurological and clinical demise, resulting in disproportionate disability for those affected. Caring for this group of patients is complex, intense, multidisciplinary in nature, and fraught with the need for expensive treatments, surveillance imaging, physician follow-up, and rehabilitative, psychological, and social support interventions. Few of these patients return to the workforce for any meaningful time frame, and because of the enormity of the financial burden that patients, their caregivers, and society face, utilization reviews become the focus of ethical scrutiny.

